BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Honda F, Tsuboi H, Toko H, Ohyama A, Takahashi H, Abe S, Yokosawa M, Asashima H, Hagiwara S, Hirota T, Kondo Y, Matsumoto I, Sumida T. Recurrent Kikuchi-Fujimoto Disease Successfully Treated by the Concomitant Use of Hydroxychloroquine and Corticosteroids. Intern Med 2017;56:3373-7. [PMID: 29021444 DOI: 10.2169/internalmedicine.9205-17] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Betancur V, Net J, Chapman J, Yepes M. Kikuchi-Fujimoto-like lymphadenopathy following COVID-19 vaccine: diagnosis and management. BMJ Case Rep 2022;15. [PMID: 36585044 DOI: 10.1136/bcr-2022-252030] [Reference Citation Analysis]
2 Carrasco-molina S, Álvarez-troncoso J, Robles-marhuenda Á, Arnalich-fernández F. Importancia de la asociación entre la enfermedad de Kikuchi y el lupus erimatoso sistémico. Rev Esp Casos Clin Med Intern 2022;7:9-11. [DOI: 10.32818/reccmi.a7n1a4] [Reference Citation Analysis]
3 Fiori M, Spina P, Monotti R, Salvadé I. Abdominal Kikuchi-Fujimoto lymphadenopathy: an uncommon presentation of a rare disease. BMJ Case Rep 2022;15:e244732. [PMID: 35210223 DOI: 10.1136/bcr-2021-244732] [Reference Citation Analysis]
4 Al Manasra AR, Al-Domaidat H, Aideh MA, Al Qaoud D, Al Shalakhti M, Al Khatib S, Fataftah J, Al-Taher R, Nofal M. Kikuchi-Fujimoto disease in the Eastern Mediterranean zone. Sci Rep 2022;12:2703. [PMID: 35177750 DOI: 10.1038/s41598-022-06757-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Madhu V, Sreedharan R, Vinukumar V. Kikuchi disease: An unusual cause of cervical lymphadenopathy in a young female. IJMS 2021;73:357-359. [DOI: 10.25259/ijms_386_2021] [Reference Citation Analysis]
6 Loh CH, Tang PY, Lee HY. Erythematous papular eruption of acute onset in a 51-year-old male. Int J Dermatol 2021;60:953-5. [PMID: 33686645 DOI: 10.1111/ijd.15455] [Reference Citation Analysis]
7 Hussain A, Gondal M, Yousuf H, Iqbal M. Baffled with fever and lymphadenopathy: neither infection nor malignancy, think Kikuchi disease. BMJ Case Rep 2021;14. [PMID: 33509881 DOI: 10.1136/bcr-2020-238914] [Reference Citation Analysis]
8 Jiwani RA, Jourdan DN, Pona A, Donthi D, Stalls JS, Rehana RW. Kikuchi Fujimoto disease: sinister presentation, good prognosis. J Community Hosp Intern Med Perspect 2021;11:72-5. [PMID: 33552420 DOI: 10.1080/20009666.2020.1824332] [Reference Citation Analysis]
9 Park S, Kim JY, Ryu YJ, Lee H. Kikuchi Cervical Lymphadenitis in Children: Ultrasound Differentiation From Common Infectious Lymphadenitis. J Ultrasound Med 2021;40:2069-78. [PMID: 33263358 DOI: 10.1002/jum.15584] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
10 Aun JA, Hubbard MJ. Kikuchi-Fujimoto Disease Heralding Systemic Lupus Erythematosus. Journal of Osteopathic Medicine 2020;120:934-939. [DOI: 10.7556/jaoa.2020.137] [Reference Citation Analysis]
11 Jung HJ, Lee IJ, Yoon SH. Risk Assessment of Recurrence and Autoimmune Disorders in Kikuchi Disease. Risk Manag Healthc Policy 2020;13:1687-93. [PMID: 33061702 DOI: 10.2147/RMHP.S271283] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
12 Shorkey AK, Laxer RM, Friedman JN. A 10-year-old girl with cervical lymphadenopathy, fever, and cytopenia. Paediatrics & Child Health 2020;25:342-344. [DOI: 10.1093/pch/pxz114] [Reference Citation Analysis]
13 Salamat S, Chan J, Jolly K, Powell G, Harrison K, Ahanger S, Hari C. Kikuchi-Fujimoto Disease and Prognostic Implications. Head Neck Pathol 2020;14:272-5. [PMID: 30888636 DOI: 10.1007/s12105-019-01026-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]